CORC

浏览/检索结果: 共103条,第1-10条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Force Feedback Control of a Robotic Needle Insertion into Layered Soft Tissues 会议论文
Stuttgart, Germany, November 20-22, 2018
作者:  Yang TW(杨唐文);  Xiao, Lifang;  Chen PF(陈盼飞);  Zhu, Haifeng;  Zhao XG(赵新刚)
收藏  |  浏览/下载:36/0  |  提交时间:2019/03/09
A Road-Aware Spatial Mapping for Moving Objects 会议论文
Florida, 2018
作者:  Xingsheng Zhao;  Jingwen Shi;  Mingzhe Du;  Fan Ni;  Yang Wang
收藏  |  浏览/下载:30/0  |  提交时间:2019/01/31
SHMstor: A Scalable Hadoop/MapReduce-based Storage System for Small-Write Efficiency 会议论文
广州, 2018
作者:  Lingfang Zeng;  Wei Shi;  Fan Ni;  Song Jiang;  Xiaopeng Fan
收藏  |  浏览/下载:18/0  |  提交时间:2019/01/31
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Increased Bronchoalveolar Lavage Fluid Peroxiredoxin 6 Levels in Acute Respiratory Distress Syndrome 会议论文
作者:  Yang, D.;  Wang, C.;  Liu, J.;  Chen, C.;  Song, Y.
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu
收藏  |  浏览/下载:39/0  |  提交时间:2019/12/05
Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas 会议论文
作者:  Zhu, Jun;  Cao, Junning;  Qiu, Lugui;  Qi, Junyuan;  Song, Yuqin
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506) 会议论文
作者:  Yu, P.;  Zhou, Q.;  Song, Y.;  Zhang, X.;  Chen, G.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y.
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace